![Stephen Thomas](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stephen Thomas
Direttore/Membro del Consiglio presso ELIEM THERAPEUTICS, INC.
Patrimonio netto: 801 123 $ in data 31/05/2024
Provenienza dei contatti di primo grado di Stephen Thomas
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Public Company | Biotechnology | 8 | |
Ichorion Therapeutics, Inc.
![]() Ichorion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ichorion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of treatments for rare diseases. It focuses on a pipeline of genetically-targeted therapies for inherited metabolic disorders known as Inborn Errors of Metabolism. The company was founded by Stephen Thomas on July 7, 2017 and is headquartered in New York, NY.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Stephen Thomas tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Convergence Pharmaceuticals Ltd.
![]() Convergence Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Convergence Pharmaceuticals Ltd. develops novel analgesics for the treatment of chronic pain. It provides CNV1014802, a small molecule state-dependent sodium channel blocker; and CNV1061436, a sodium channel blocker for the treatment of central nervous system disorders, including epilepsy and bipolar disorder. The company was founded by Brenda Reynolds in September 2010 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Founder Corporate Officer/Principal Corporate Officer/Principal | |
Arvinas Operations, Inc.
![]() Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | Biotechnology | Director/Board Member Director/Board Member | |
RA Capital Management LP (Private Equity)
![]() RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | Investment Managers | Private Equity Investor Private Equity Investor | |
ARVINAS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
GlaxoSmithKline, Inc.
![]() GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Superluminal Medicines Inc
![]() Superluminal Medicines Inc BiotechnologyHealth Technology Superluminal Medicines Inc is a generative biological and chemical company. The company is based in Boston, MA. The CEO of the company is Cony D'Cruz. | Biotechnology | Director/Board Member | |
Harvard Medical School | College/University | Doctorate Degree | |
Clinton Health Access Initiative
![]() Clinton Health Access Initiative Miscellaneous Commercial ServicesCommercial Services The Clinton Health Access Initiative (CHAI) is a health organization that is dedicated to saving lives, reducing the burden of disease, and strengthening health systems. CHAI is based in Boston, MA, and the CEO of the non-profit company is Deepak Verma. The organization's focus is on improving healthcare in developing countries. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Lusaris Therapeutics, Inc.
![]() Lusaris Therapeutics, Inc. BiotechnologyHealth Technology Lusaris Therapeutics, Inc. is a biotechnology company that focuses on developing next-generation serotonergic neuroplastogen therapeutics to treat severe neuropsychiatric and neurological disorders. The company is based in Boston, MA. The company's lead program, LSR-1019, is a proprietary sublingual formulation of 5-MeO-DMT, a rapidly acting and rapidly clearing serotonergic psychedelic, which is being developed to treat treatment-resistant depression and other neuropsychiatric conditions. The company's pipeline also includes novel neuroplastogens for a wide range of neuropsychiatric and neurological conditions, including migraine and cluster headache. The CEO of the company is Andrew D. Levin. | Biotechnology | Chief Executive Officer | |
Imbria Pharmaceuticals, Inc.
![]() Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Founder | |
Clear Creek Bio, Inc.
![]() Clear Creek Bio, Inc. Pharmaceuticals: MajorHealth Technology Clear Creek Bio, Inc. engages in the development of therapies that target nucleotide synthesis pathways. The firm focuses on the differentiation blockade in cancer and suppress replication of RNA-based viruses. It uses pharmacodynamic markers to ensure that each patient gets the right drug at the correct dose. The company was founded by David T. Scadden, David B. Sykes, Burt A. Adelman, and Vikram Sheel Kumar in 2017 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Bridge Valley Ventures LLP
![]() Bridge Valley Ventures LLP Investment ManagersFinance Bridge Valley Ventures LLP is a Venture Capital firm founded in 2017. Bridge Valley Ventures LLP is headquartered in Cambridge. | Investment Managers | Private Equity Investor | |
SYNTHORX, INC. | Biotechnology | Director/Board Member | |
RA Capital Management LP
![]() RA Capital Management LP Investment ManagersFinance RA Capital Management LP (RA Capital) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in Boston, Massachusetts. The firm was founded by Peter Kolchinsky in 2004. RA Capital provides discretionary investment advisory services to Healthcare Funds and the Nexus Funds which are open only to certain financially sophisticated and high net-worth individuals and entities. | Investment Managers | Portfolio Manager-Equities | |
H.I.G Capital LLC (Private Equity)
![]() H.I.G Capital LLC (Private Equity) Investment ManagersFinance H.I.G. Capital LLC (H.I.G Capital) is a private equity division of H.I.G. Capital LLC founded in 1993 by Sami W Mnaymneh and Anthony A Tamer. The firm is headquartered in Miami, Florida with offices in Europe, Latin America and Middle East. | Investment Managers | Private Equity Investor | |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
Clinton Group, Inc.
![]() Clinton Group, Inc. Investment ManagersFinance Clinton Group, Inc. is a registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by George E. Hall in 1991 and is a subsidiary of Madison Avenue Capital Holdings, Inc., which is owned by CGI Holdings, Inc. Clinton Group serves as investment manager primarily for an offshore private investment fund, as well as pools of collateralized debt obligations (CDOs), collateralized bond obligations (CBOs) and other structured products for which the the firm as collateral manager. | Investment Managers | Corporate Officer/Principal | |
Princeton University | College/University | Undergraduate Degree | |
H.I.G. BioHealth Partners LLC
![]() H.I.G. BioHealth Partners LLC Investment ManagersFinance H.I.G. BioHealth Partners LLC (H.I.G. BioHealth Partners) is a private equity and venture capital subsidiary of H.I.G. Ventures LLC founded in 1993. The firm is headquartered in Miami, Florida with additional offices around the globe. | Investment Managers | Private Equity Investor | |
BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
GlaxoSmithKline LLC
![]() GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
INTERMEDIATE CAPITAL GROUP PLC | Financial Conglomerates | Corporate Officer/Principal | |
Rochester Christian University | College/University | Undergraduate Degree | |
DomainTools LLC
![]() DomainTools LLC Packaged SoftwareTechnology Services DomainTools provides security system threat intelligence. Its products include IRIS investigation platform, phisheye, API integration, and personal domain research. The firm solutions include threat hunting, regulatory compliance, online fraud investigation, and phishing detection. The company is headquartered in Seattle, WA. | Packaged Software | Comptroller/Controller/Auditor | |
University of California, Los Angeles | College/University | Graduate Degree | |
University of Illinois | College/University | Undergraduate Degree | |
AVALO THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Sumitomo Pharma America, Inc.
![]() Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
FULCRUM THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Wesleyan University | College/University | Doctorate Degree | |
University Of Dundee | College/University | Graduate Degree | |
SEELOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Evolution Research Group LLC
![]() Evolution Research Group LLC Miscellaneous Commercial ServicesCommercial Services Evolution Research Group LLC provides in-patient and out-patient clinical trial services to pharmaceutical companies. It specializes in psychiatric and neurological disorders, sleep disorders, addictions, acute and chronic pain, renal insufficiency and hepatic impairment, and normal healthy volunteers. The company was founded in 2014 and is headquartered in New Providence, NJ. | Miscellaneous Commercial Services | Director/Board Member | |
New York Biotechnology Association, Inc.
![]() New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | Miscellaneous Commercial Services | Chairman | |
Eliem Therapeutics (UK) Ltd.
![]() Eliem Therapeutics (UK) Ltd. BiotechnologyHealth Technology Founded in 2019, Eliem Therapeutics (UK) Ltd. is a British company that engages in research and development on biotechnology. Part of Eliem Therapeutics, Inc., the company is based in Altrincham, UK. | Biotechnology | Director/Board Member | |
Université de Bordeaux | College/University | Graduate Degree | |
Massachusetts Institute of Technology | College/University | Doctorate Degree | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Tang Capital Management LLC
![]() Tang Capital Management LLC Investment ManagersFinance Tang Capital Management LLC (Tang Capital) is an independent hedge fund manager headquartered in San Diego, California. The firm was founded by Kevin Tang in 2002. Tang Capital provides investment advice to high-net-worth clients. | Investment Managers | Analyst-Equity | |
New Leaf Venture Partners LLC
![]() New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Venture Partners LLC (New Leaf Ventures) is an independent Venture Capital firm founded by Jeani Delagardelle, Philippe Chambon, Vijay Lathi, Ron Hunt, James Niedel, and Kathy LaPorte. The firm is headquartered in New York. It spun out from Sprout Group. | Investment Managers | Private Equity Investor | |
Citadel Advisors LLC
![]() Citadel Advisors LLC Investment ManagersFinance Citadel Advisors LLC is a SEC-registered investment advisor and hedge fund manager headquartered in Miami, Florida. The firm was founded in 1990 by Kenneth Griffin and is wholly-owned by Citadel Advisors Holdings LP, ultimately held by GFH HFEVA LLC. Citadel Advisors manages private investment funds that are offered exclusively to sophisticated investors. | Investment Managers | Analyst-Equity | |
COGENT BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
PASSAGE BIO, INC. | Biotechnology | Director/Board Member | |
CuraSen Therapeutics, Inc.
![]() CuraSen Therapeutics, Inc. BiotechnologyHealth Technology CuraSen Therapeutics, Inc. operates as a biotechnology company. It engages in the discovery and development of therapies to treat neurodegenerative diseases, including parkinson, alzheimer, and less common neurodegenerative disorders. The company was founded by Mehrdad Shamloo, Robert Booth, Anthony Ford, and Kathleen Sereda in 2018 and is headquartered in San Mateo, CA. | Biotechnology | Director/Board Member | |
Rallybio LLC
![]() Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT. | Miscellaneous Commercial Services | Director/Board Member | |
DECIPHERA PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
Stati Uniti | 40 |
Regno Unito | 9 |
Canada | 2 |
Francia | 2 |
Settori
Health Technology | 26 |
Finance | 12 |
Consumer Services | 9 |
Commercial Services | 5 |
Technology Services | 2 |
Posizioni
Director/Board Member | 48 |
Corporate Officer/Principal | 17 |
Independent Dir/Board Member | 16 |
Chief Executive Officer | 10 |
Chairman | 7 |
Contatti più connessi
Insiders | |
---|---|
Liam Ratcliffe | 32 |
Andrew Levin | 21 |
Adam Rosenberg | 13 |
Simon Tate | 9 |
Judith Dunn | 8 |
Valerie Morisset | 5 |
Patrick Crutcher | 5 |
Joanne Palmer | 3 |
Emily Pimblett | 3 |
- Borsa valori
- Insiders
- Stephen Thomas
- Connessioni Società